BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:With lipid nanoparticles moving beyond mRNA vaccines\, biophar ma are racing against the clock to exploit clinical utility to deliver mo re complex payloads\, while optimising scalability and product quality.\n \nFollowing industry progress of BioNTech entering LNP cancer vaccine tri als\, Moderna entering $76m collaboration with Gen Bio\, and Bayer-Acuita s Therapeutics partnership using LNP for gene therapy\, the field shows n o signs of slowing down.\n\nIn collaboration with CPI\, Pfizer\, GSK\, th is 3-day summit will reunite 100+ senior leaders\, sharing exclusive data to help you maximise this non-viral delivery system's potential. The 2nd Lipid Nanoparticle Development Europe Summit is committed to equipping y ou with actionable takeaways across end-to-end characterisation\, biodist ribution\, formulation and scale up to supercharge your LNP pipeline deve lopment with therapeutic promise to patients.\n\nUnite in October to get ahead of the curve and exploit LNP as the hottest delivery vehicle.\n\nVi sit the website for full details\, early bird and group discount informat ion.\n\nURLs:Tickets: \;https://go.evvnt.com/1842219-2?pid=185Brochur e: \;https://go.evvnt.com/1842219-3?pid=185LinkedIn: \;https://go .evvnt.com/1842219-4?pid=185\n\nPrices:Conference + 3 Workshops - Drug De veloper Pricing: EUR 4546.00\,Conference + 3 Workshops - Academic Pricing : EUR 3896.00\,Conference + 3 Workshops - Service Provider Pricing: EUR 5 546.00\,Conference + 2 Workshops - Drug Developer Pricing: EUR 3997.00\,C onference + 2 Workshops - Academic Pricing: EUR 3397.00\,Conference + 2 W orkshops - Service Provider Pricing: EUR 4987.00\,Conference Only - Drug Developer Pricing: EUR 2899.00\,Conference Only - Academic Pricing: EUR 2 399.00\,Conference Only - Service Provider Pricing: EUR 3599.00\n\nSpeake rs: \;Phil Rye\, Chief Scientific Officer\, AlgiPharma AS\, Alexander Kapustin\, Associate Principal Scientist\, AstraZeneca\, Nikolaos Daskal akis\, Senior Scientist\, Advanced Drug Delivery\, AstraZeneca\, David Di az-Oviedo\, Postdoctoral Research Scientist\, Bayer Pharmaceuticals\, Jul iana Haggerty\, Head of Centre of  \;Excellence Lipid  \;Nanopart icles\, CPI\, Emily Port\, Team Leader and  \;Principal Scientist &nb sp\;Nanopharmaceuticals\, CPI\, Laurent Strodiot\, Director R and D\, GSK \, Senior Representative\, Helix Biotech\, Senior Representative\, InProc ess-LSP\, Xiang Luo\, Scientist\, King's College London\, Alexander Kros\ , Professor\, Leiden University\, Yogev Debbi\, Co-Founder and CEO\, Mana .bio\, Dai Hayward\, CEO\, Micropore Technologies\, Ben Knappett\, Head o f Science and Applications\, Particle Works\, Giel De Winter\, Senior Tec hnical Design Lead Innovation\, Pfizer\, Senior Representative\, Precisio n Nanosystems\, Dimitrios Lamprou\, Professor\, Queen's University  \ ;Belfast\, Senior Representative\, ReciBio Pharm\, Stephen Lock\, Senior Market Development Manager\, SCIEX\, Lu Tian\, Senior Director\, LNP Plat form Lead and CMC Project Management\, STA Pharmaceutical\, Mostafa Nakac h\, Global Head of Process Engineering for Biologics Drug Product Develop ment\, Sanofi\, Selma Pereira Lopes\, Head of Drug Product Science\, The Janssen Pharmaceutical Companies of Johnson and Johnson\, Federica Sebast iani\, Assistant Professor\, University of Copenhagen\, Camilla Foged\, P rofessor of Vaccine Design and Delivery\, University of Copenhagen\, Hein rich Haas\, Professor\, University of Mainz\n\nTime: \;9:00 am to 5:0 0 pm\n DTEND:20231019T170000 DTSTAMP:20260512T231935Z DTSTART:20231017T090000 LOCATION:Mercure Amsterdam City Hotel\, 10\, Joan Muyskenweg\, Amsterdam\, Noord-Holland\, 1096 CJ\, SEQUENCE:0 SUMMARY:With lipid nanoparticles moving beyond mRNA vaccines\, biopharma a re racing against the clock to exploit clinical utility to deliver more c omplex pa... UID:5b12c79e-1b6d-42da-b86e-cfd5bbcf9389 END:VEVENT END:VCALENDAR